SEC Form 4 · accession 0001323212-26-000010
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Pauwels
Officer — CHIEF BUSINESS OFFICER
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 5:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 10, 2026 | S | 3,711 | $75.00 | D | 73,411 | D | |
| Common Stock | Jun 10, 2026 | M | 17,566 | $18.01 | A | 90,977 | D | |
| Common Stock | Jun 10, 2026 | S | 17,566 | $75.00 | D | 73,411 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $18.01 | Jun 10, 2026 | S | 17,566 | D | — | Jan 2, 2028 | Common Stock | 17,566 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026.
- F2Currently exercisable.